Salsalate improves the anti-tumor efficacy of Lenvatinib in MASH-driven hepatocellular carcinoma.
Journal Articles
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
publication date
published in
Research
keywords
-
2.1 Biological and endogenous factors
-
32 Biomedical and Clinical Sciences
-
3211 Oncology and Carcinogenesis
-
5.1 Pharmaceuticals
-
Cancer
-
Chronic Liver Disease and Cirrhosis
-
Digestive Diseases
-
Genetics
-
Liver Cancer
-
Liver Disease
-
Orphan Drug
-
Rare Diseases
Identity
Digital Object Identifier (DOI)
Additional Document Info